Stay updated with the latest business news, market trends, expert insights, and industry updates to help you stay ahead in the competitive world of business.
OP Bancorp (OPBK) shares fell 0.13% in after-hours trading after it reported a profit of $5 million in its fourth quarter, a decrease from the same quarter last year. The Los Angeles-based bank said it had earnings of 33 cents per share, led by a $21.3 million revenue net of interest expense.
Published on: January 23, 2025, 10:06 PM UTC
East West Bancorp reports Q4 earnings, beating revenue expectations but missing on earnings.
Published on: January 23, 2025, 10:06 PM UTC
Associated Banc-Corp (ASB) reported a Q4 loss of $161.6 million, or $1.03 per share. Adjusted earnings were 57 cents per share, topping estimates of 55 cents. Revenue was $600.5 million, with net interest income of $345.8 million, also above expectations. ASB shares have gained 6% YTD and 18% over the past year.
Published on: January 23, 2025, 10:06 PM UTC
SLM Corp. reported lower-than-expected earnings and revenue in the fourth quarter, with adjusted revenue falling short of Wall Street forecasts.
Published on: January 23, 2025, 10:05 PM UTC
Midland States Bancorp, Inc. (MSBI) reported a Q4 loss of $52.5 million, missing analysts' estimates. Revenue was $121.5 million, with net interest income exceeding expectations.
Published on: January 23, 2025, 10:05 PM UTC
Texas Instruments' disappointing earnings forecast reflects ongoing chip demand challenges and higher production costs. Despite outperforming analysts' estimates in Q4, the outlook suggests manufacturing expansion pressures on profits.
Published on: January 23, 2025, 10:05 PM UTC
Texas Instruments Q4 earnings beat estimates but outlook falls short, sending shares lower after the bell.
Published on: January 23, 2025, 10:05 PM UTC
JPMorgan Chase CEO Jamie Dimon's annual compensation rose 8.3% to $39 million in 2024.
Published on: January 23, 2025, 10:04 PM UTC
Amazon Resumes Green Card Applications, May Signal Future Growth Goals
Published on: January 23, 2025, 10:04 PM UTC
Trump reverses Biden's $2 generic drug list, signaling a shift in healthcare policy.
Published on: January 23, 2025, 10:03 PM UTC